NMS GROUP ONCOLOGY FORWARD Trademark

Trademark Overview


On Friday, July 9, 2021, a trademark application was filed for NMS GROUP ONCOLOGY FORWARD with the United States Patent and Trademark Office. The USPTO has given the NMS GROUP ONCOLOGY FORWARD trademark a serial number of 79323839. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by NMS GROUP S.P.A.. The NMS GROUP ONCOLOGY FORWARD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, technological, analysis and research services, namely, research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services
nms group oncology forward

General Information


Serial Number79323839
Word MarkNMS GROUP ONCOLOGY FORWARD
Filing DateFriday, July 9, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6966082
Registration DateTuesday, January 31, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Description of MarkThe mark consists of the stacked stylized wording "NMS GROUP," in block letters, and "ONCOLOGY FORWARD".
NOT AVAILABLE"GROUP ONCOLOGY"
Goods and ServicesScientific, technological, analysis and research services, namely, research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNMS GROUP S.P.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameNMS GROUP S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameNMS GROUP S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events


Event DateEvent Description
Tuesday, April 5, 2022ASSIGNED TO LIE
Friday, October 22, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 30, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, March 29, 2022ASSIGNED TO EXAMINER
Tuesday, April 5, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 18, 2022REFUSAL PROCESSED BY MPU
Wednesday, May 18, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 6, 2022REFUSAL PROCESSED BY IB
Monday, September 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 12, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 4, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, November 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 23, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 4, 2023FINAL DISPOSITION PROCESSED
Thursday, May 4, 2023FINAL DISPOSITION NOTICE SENT TO IB